Princeton Bancorp director Martin Tuchman acquires $32,672 in stock

Published 13/05/2025, 16:58
Princeton Bancorp director Martin Tuchman acquires $32,672 in stock

Martin Tuchman, a director and significant shareholder of Princeton Bancorp, Inc. (NASDAQ:BPRN), recently made notable stock acquisitions in the $223.6 million market cap bank. According to a recent SEC filing, Tuchman acquired a total of 1,021 shares of common stock over two transactions. InvestingPro analysis shows the stock trading at an attractive 0.84x price-to-book value, with a healthy 3.7% dividend yield. The purchases, which took place on May 9 and May 12, 2025, were made at a consistent price of $32 per share, resulting in a total transaction value of $32,672.

Following these acquisitions, Tuchman now directly owns 111,788 shares of Princeton Bancorp. Additionally, he indirectly holds 629,141 shares as a trustee of the Martin Tuchman Revocable Trust. These transactions reflect Tuchman’s ongoing confidence in the company’s prospects.

In other recent news, Privia Health Group, Inc. reported fourth-quarter results that exceeded analyst expectations, with adjusted earnings per share at $0.21, surpassing the estimated $0.05. The company achieved quarterly revenue of $460.9 million, beating the consensus forecast of $420.94 million and marking a 4.6% increase from the previous year. However, Privia Health’s 2025 revenue guidance of $1.8-1.9 billion fell short of analysts’ expectations, which were set at $1.89 billion. The company attributed this shortfall to challenges in the Medicare Advantage and value-based care sectors.

Princeton Bancorp, Inc., the parent company of The Bank of Princeton, announced a quarterly cash dividend of $0.30 per share, payable to shareholders of record as of May 6, 2025. The decision reflects the Board of Directors’ ongoing commitment to providing returns to shareholders. Additionally, Princeton Bancorp recently held its annual meeting, where shareholders elected eight directors and approved executive compensation and the appointment of Wolf & Company, P.C. as independent auditors for the fiscal year ending December 31, 2025.

These developments indicate ongoing strategic decisions and financial planning within the companies. While Princeton Bancorp continues to focus on shareholder returns and governance, Privia Health is navigating a complex healthcare environment with a focus on growth in provider numbers and adjusted EBITDA for 2025.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.